Codex DNA Inc
Change company Symbol lookup
Select an option...
DNAY Codex DNA Inc
VTR Ventas Inc
LTC LTC Properties Inc
CNK Cinemark Holdings Inc
TITN Titan Machinery Inc
AHL-C Aspen Insurance Holdings Ltd
EVBN Evans Bancorp Inc
CTXS Citrix Systems Inc
RY Royal Bank of Canada
MCIOF MCI Onehealth Technologies Inc

Company profile

Codex DNA, Inc. is a synthetic biology company focused on enabling researchers to build or write synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA). Its synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the limitations of existing solutions that prevent the building of DNA and mRNA at a useable scale. Its BioXp system is an end-to-end automated workstation. It has developed and commercialized products, which include BioXp systems, including BioXp 3250 system, BioXp kits for generating an array of synthetic DNA and mRNA, and benchtop reagents that complement the automated synthetic biology workflow applications and workflow solutions. It has launched eight BioXp kits, three benchtop reagent kits, and various other synthetic biology products, including 14 SARS-CoV-2 full-length genomes and RNA controls, as well as its Vmax X2 cells. It has placed approximately 200 BioXp systems globally.

Day's Change
-0.18 (-4.05%)
B/A Size
Day's High
Day's Low

Today's volume of 49,650 shares is on pace to be much lighter than DNAY's 10-day average volume of 109,755 shares.

  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    2:49p ET 05/18/22
  • Last (size)
  • 52-Wk Range
    3.43 - 25.70
  • (06/30/21 - 05/11/22)
  • 112.7%
  • Market Cap
  • Shares Outstanding
  • -1.52
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 58.65
  • (% of float 04/29/22)

Latest News

May 10, 2022
4:05 pm ET
Globe Newswire
May 03, 2022
8:03 am ET
Globe Newswire
April 27, 2022
8:03 am ET
Globe Newswire
April 26, 2022
8:03 am ET
Globe Newswire
April 18, 2022
3:48 pm ET
Globe Newswire
April 06, 2022
10:57 am ET
Globe Newswire
March 28, 2022
6:03 am ET
March 22, 2022
4:05 pm ET
Globe Newswire
March 03, 2022
8:03 am ET
Globe Newswire
March 02, 2022
8:03 am ET
Globe Newswire
February 24, 2022
10:56 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.